Valora Therapeutics Inc. (Valora) is a pre-clinical stage biopharmaceutical company based in San Diego, California, USA, pioneering a new biologic platform invented by Nobel Laureate Dr. Carolyn Bertozzi (Stanford). Our proprietary platform technology enables the engineering of chimeric antibodies to unlock new mechanisms of immune signaling and activity, paving the way for transformative therapies in oncology, immune diseases, and beyond.
Total raised: $30M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.11.2024 | Seed | $30M | - |
Mentions in press and media 4
| Date | Title | Description |
| 24.11.2024 | Valora Therapeutics Secures $30 Million to Revolutionize Immunotherapy | In the world of biotechnology, innovation is the lifeblood. Valora Therapeutics, a San Diego-based company, has just injected $30 million into its veins. This seed funding, led by Avalon BioVentures, Bregua Corporation, and TigerGene, is a ... |
| 21.11.2024 | Valora Therapeutics: $30 Million (Seed) Raised To Pioneer Novel Approach To Immunotherapy | Valora Therapeutics – a biotechnology company pioneering a novel approach to immunotherapy – announced the closing of its seed funding round. The funding round was co-led by Avalon BioVentures together with Bregua Corporation and TigerGene,... |
| 20.11.2024 | Valora Therapeutics Raises $30M in Seed Financing | Valora Therapeutics, a San Diego, CA-based biotechnology company providing a novel approach to immunotherapy, raised $30M in Seed funding. The round wad led by Avalon BioVentures, together with Bregua Corporation and TigerGene. Additional p... |
| - | Valora Therapeutics | “Valora” |